King Wealth Pacira Bio Sciences, Inc. Transaction History

King Wealth

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$30.8 - $52.47 $246,400 - $419,760	-8,000 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$28.4 - $50.7 $227,200 - $405,600	8,000 New	8,000 $268,000
Q4 2019 Feb 13, 2020	SELL	$36.31 - $46.83 $326,790 - $421,470	-9,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$35.66 - $44.99 $320,939 - $404,910	9,000 New	9,000 $343,000

266

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $761M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

Stay updated on King Wealth with notifications on news.